[ad_1]
The award-winning solution will be available to view ahead of its general availability at the Innovation Awards Showcase, the CONNECTIONS Summit at CES, and the company’s CES exhibition suite (29-221), details of which can be found. on the dedicated InSight + web page of the company’s website.
“We look forward to sharing more about our passive sensing technology with show attendees,” said Matt johnson, CEO of EarlySense. “With the pandemic still firmly entrenched with us, we know that we will continue to see an explosion of use cases for patients who want to be cared for at home and for providers who want to integrate virtual care solutions into their practices at home. long term. ”
The EarlySense InSight + system is based on the company’s medical grade technology and redesigned for the home. It uses a contactless sensor under the mattress to continuously and passively collect patient biometric data. The solution’s cellular vital signs processing unit, powered by AT&T IoT, securely analyzes and transmits key vital signs, motion and sleep data to the EarlySense cloud, where they can be integrated with health management systems. care and dashboards.
Data collected from patients via InSight + includes sleep phases, sleep trends, sleep score, nighttime breathing patterns, heart rate, heart rate variability, respiratory rate, respiratory rate variability and body movement levels, as well as clinical marker alerts related to heart rate instability. and respiratory rate depression.
“We are thrilled to team up with EarlySense to help provide care to more patients who need it, from the comfort of their homes,” said Joe drygas, AT&T vice president of healthcare solutions. “A reliable and highly secure connection is essential for remote patient monitoring. ”
Using years of data from its hospital monitoring solutions, the solution applies intelligent pattern detection and artificial intelligence (AI) models to create a dynamic baseline for patients, then signals subtle changes in patterns. vital signs of patients, to help healthcare providers visualize meaningful health. changes and identify the first signs of patient deterioration.
Not expected to be widely available until the second half of 2022, EarlySense makes InSight + available for clinical research, giving rapid access to proprietary surveillance technology to augment ongoing clinical efforts in telehealth, passive surveillance and AI-based health initiatives.
“We are truly excited about the opportunity to partner with researchers, technology developers and clinical service providers who are as passionate as we are about advancing virtual home care solutions,†said Terry duesterhoeft, Product Manager and Sales Director, EarlySense. “This initiative will allow us to support studies and develop new applications to provide a more complete picture of the true health of patients, with vital signs data continuously captured overnight – when it is most stable in the world.” collect data. ”
Researchers interested in partnering with EarlySense can visit the company’s website.
About EarlySense:
EarlySense® is the global leader in 100% continuous and contactless monitoring solutions. Used worldwide in hospitals, post-acute care and home care settings, the company’s predictive data science technology and applications provide providers, clinicians and patients with continuous multi-vital data and actionable insights that improve quality of life and patient outcomes across the continuum of care. . EarlySense is based in Ramat Gan, Israel and Woburn, Massachusetts. For more information, visit the company’s website at www.earlysense.com.
SOURCE EarlySense
[ad_2]
Comments are closed.